There have been multiple published studies regarding the difficulties and errors with administering small doses of medication, primarily for infants and small children. Exacerbating the issue is the fact that small doses for young patients are often prepared from stock of less than 0.1mL in size, yet the equipment does not permit the accurate measurements of volumes that small. A study from the Canadian Medical Association Journal on this subject found 17.5% of children and babies need preparations of less than 0.2 mL and concluded a substantial source of dosing error involved more than 25% of the children studied. Adverse drug event (ADE) rates are generally the highest among children up to age 5.
Pedia-Dose® utilizes a uniquely designed Safe-T-Syringe® that is comprised of a calibrated reduced volume barrel with multiple correlating indicia. This design provides an enhanced lower incremental dosing, while in parallel extending the indicia display of the Safe-T-Syringe® for precise accuracy in dosing of the medication. The custom indicia may also be designed to target individual patient weight class or body surface area for ultra-sensitive or potent medications, further increasing the accuracy of preparation and administration.
The unique design of the Safe-T-Syringe® indicia for the Pedia-Dose® also enables the downsizing of the medication vial to individual patient class, weight, BSA or other feature. This “designed dosage” to individual patient class creates tremendous cost savings versus the typical waste of medication from traditional dose products. In addition, the reduction in waste offers a decrease in environmental impact and disposal costs.
- Not available in all territories
- The Safe-T-Dose® and Pedia-Dose® are registered trademarks of Asepsis Medical Technologies, LLC., and covered by one or more patents, including; U.S. Patent 9,192,723, U.S. Patent 9,302,050, U.S Patent 9,750,883, U.S. Patent 10,857,299 and International Patents; AU2013222819, AU2016269509, AU2018232988, CA2862633, CA3006218, MX351645, MX17/012034, JP2015-508321 and Patents Pending.